Sopharma (BGSFA)

3.28
-0.02(-0.61%)
  • Volume:
    1,235
  • Bid/Ask:
    3.94/3.99
  • Day's Range:
    3.28 - 3.28

BGSFA Overview

Prev. Close
3.3
Day's Range
3.28 - 3.28
Revenue
2.47B
Open
3.28
52 wk Range
2.7 - 3.52
EPS
0.24
Volume
1,235
Market Cap
412.58M
Dividend (Yield)
0.04 (3.33%)
Average Vol. (3m)
5,524
P/E Ratio
13.93
Beta
0.72
1-Year Change
15.09%
Shares Outstanding
125,786,432
Next Earnings Date
May 27, 2021
What is your sentiment on Sopharma?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSell
Technical IndicatorsStrong SellStrong Buy
SummaryStrong SellNeutral

Sopharma Company Profile

Sopharma Company Profile

Sector
Services
Employees
5099
Market
Bulgaria

Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.